chrisvoncsefalvay/vaers-outcomes huggingface dataset:
chills; extremely dry mouth where she feels like she has no saliva; extremely dry mouth where she feels like she has no saliva; extremely tired; had a strange sensation of tingling in her skull, back of neck, and up her skull. Tingling sensation is more left sided than right/the tingling sensation in her head; This is a spontaneous report received from a contactable nurse (who is also the patient). A 63-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899, expiry date: Mar2021), via an unspecified route of administration, on 22Dec2020, at single dose, for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient reported that on 23Dec2020, she had a strange sensation of tingling in her skull, back of neck, and up her skull. Tingling sensation was more left sided than right. On24Dec2020, she experienced chills, which she knows is one of the normal effects. She also experienced an extremely dry mouth to where she feels like she has no normal saliva on 24Dec2020. She was constantly drinking ice water. She was also extremely tired. The patient reported that the most concerning to her is the tingling sensation in her head and the extreme dry mouth. The patient wanted to know if what she is experiencing is ok or not. She also reported that "if it's urgent she cannot wait until USMI reopens, she will go to the ER". The outcome of the events was unknown.
Odd gait when walking/running on 4/1. Feet tingled on 4/2. Limping by 4/3 and began falling frequently. ER on 4/7 and diagnosed with Guillain-Barre Syndrom on 4/8.
SIDE EFFECTS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported. On an unspecified date, the subject experienced side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of side effects was not reported. This report was non-serious.
tonic-clonic seizures; Husband is now an epileptic; started convulsing; stop breathing; lots of blood coming out of his mouth; This spontaneous case was reported by a consumer and describes the occurrence of SEIZURE (started convulsing), GENERALISED TONIC-CLONIC SEIZURE (tonic-clonic seizures) and EPILEPSY (Husband is now an epileptic) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 036B26A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Appendectomy.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-May-2021, the patient experienced SEIZURE (started convulsing) (seriousness criterion medically significant), DYSPNOEA (stop breathing) and MOUTH HAEMORRHAGE (lots of blood coming out of his mouth). On 22-Jul-2021, the patient experienced GENERALISED TONIC-CLONIC SEIZURE (tonic-clonic seizures) (seriousness criterion medically significant) and EPILEPSY (Husband is now an epileptic) (seriousness criterion medically significant). At the time of the report, SEIZURE (started convulsing), DYSPNOEA (stop breathing), MOUTH HAEMORRHAGE (lots of blood coming out of his mouth), GENERALISED TONIC-CLONIC SEIZURE (tonic-clonic seizures) and EPILEPSY (Husband is now an epileptic) outcome was unknown.            Weeks after taking his second dose of the Moderna COVID-19 vaccine, on 24May2021, the patient started having convulsions, stopped breathing and his wife had to bring him to the hospital. Also started having lots of blood coming out of his mouth, at the hospital they said he could have bitten himself when having convulsions but they could not find signs of that. On 22Jul2021 the same thing happened, he started having convulsions, but there was no blood coming out of his mouth this time. The patient is now an epileptic and wife thinks he is screwed and she's scared that she may loose him. They said they're tonic-clonic seizures.   Patient did not take any medications prior to this.  Concomitant medications information not reported. Treatment information not reported.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, more information is required for further assessment.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, more information is required for further assessment.
Pfizer-BioNTech COVID-19 Vaccine EUA: one day after vaccination patient brought in by ambulance to emergency department (ED) for generalized tonic-clonic seizures. Patient experienced first seizure and treated, evaluated, and released from ED at another facility. Patient experienced another seizure at home and brought to this facility. Patient experienced a third seizure in the ED, antiepileptic medication was initiated, patient was admitted then discharged the next day stable on antiepileptic medication and follow-up in place. On subsequent follow-up visit with primary care patient reported no seizures but back pain. Found to have a thoracic compression fracture from seizures prior to hospital admission. On neurology follow-up continues to be seizure-free and compliant with antiepileptic medication. Diagnosed with focal epilepsy and will continue to be followed by outpatient neurology.
Shortness of breath, She reports that is feels like her seasonal allergies but was told to talk to a doctor. Advised to use her inhaler that she normally uses for her symptoms and if not completely better needs in person evaluation.
PAIN AND REDNESS AT SITE OF INJECTION, HEADACHE, FEVER, FATIGUE, CHILLS, MUSCLE AND JOINT PAIN, THEETH AND MOUTH PAIN, VOMITING, BODY PAIN, LOSS OF APPETITE.  TIME COURSE- WORST SYMPTOMS - TWO DAYS                                       MILD SYMPTOMS-  ONE DAY
Less than 24 hours post vax, the pt developed a full body rash described as erythematous, macular mostly on legs and chest. It was accompanied by low-grade fever and fussiness. No signs of illness prior to IZ. Fully recovered within 5 days.
"The biggest problem I had was the rash, it was almost unbearable at times, it itched so much"; The patient reported that the rash extended from the injection site to her elbow and "lasted 4 days or so; Fever; "Nauseated at times"; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC ("The biggest problem I had was the rash, it was almost unbearable at times, it itched so much"), RASH PAPULAR (The patient reported that the rash extended from the injection site to her elbow and "lasted 4 days or so), NAUSEA ("Nauseated at times") and PYREXIA (Fever) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced NAUSEA ("Nauseated at times"). On an unknown date, the patient experienced RASH PRURITIC ("The biggest problem I had was the rash, it was almost unbearable at times, it itched so much"), RASH PAPULAR (The patient reported that the rash extended from the injection site to her elbow and "lasted 4 days or so) and PYREXIA (Fever). The patient was treated with CORTISONE for Rash and Itching, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, RASH PRURITIC ("The biggest problem I had was the rash, it was almost unbearable at times, it itched so much"), RASH PAPULAR (The patient reported that the rash extended from the injection site to her elbow and "lasted 4 days or so), NAUSEA ("Nauseated at times") and PYREXIA (Fever) had resolved.            No concomitant medications were reported.   This case was linked to MOD-2021-024105 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Aug-2021: Follow-up contains non-significant information. The contact information was updated.
Patient's spouse called at 6:30pm on 10/13/20 to report that patient was experiencing chills, nausea, and achiness.
Client unable to communicate in English, translation done by her son.  Client complained of left arm and shoulder swelling following vaccination.  Benadryl IM offered by Dr but refused as driving.  Did agree to take po Benadryl she had at home.  Blood Pressure 144/87 and pulse 70.  No breathing issues.  oxygen saturation was 100%. Released by Dr to home.
A female patient, whose age, date of birth, medical history and concomitant medications were not reported, received a dose of FLUZONE vaccine (Lot number: unknown) intramuscularly in the left arm on 23 August 2012. On 24 Sep 2012, 1 day after the vaccination, the patient felt  his arm was stiff and experienced pain with limb movement. Concomitant medications and laboratory investigations were not reported. The patient's outcome was not recovered. Documents held by sender: None.
COVID 19; COVID 19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Sep2022 as dose 3 (booster), single at the age of 61 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 and included treatment with Paxlovid.  No follow-up attempts are possible. No further information is expected.
This case was reported by a pharmacist via call center representative and described the occurrence of chills in a 50-year-old female patient who received BOOSTRIX (batch number 594SR, expiry date 18th July 2019). On 23rd June 2017, the patient received BOOSTRIX. On 24th June 2017, 1 days after receiving BOOSTRIX, the patient experienced chills. On an unknown date, the outcome of the chills was unknown. The reporter considered the chills to be possibly related to BOOSTRIX. Additional details were provided as follows: The concomitant vaccines or medications were not reported. The reporting pharmacist was the patient who experienced chills. She denied reporting any other adverse events.
Two days after receiving the shingles vaccine on April 3, 2009  I had flu like smyptoms.  Headache, sleepless nights, chills, achy all over,very weak, for three days.
Patient received COVID Pfizer Bivalent booster instead of scheduled Pfizer Monovalent dose #2 at 11/15/22 visit.  No harm to patient/adverse reaction.  In process of notifying family as to plan for series/booster once finalized by Dept of Health.
(This is actually my second ?First? shot because the first one was deemed possibly ineffective due to storage issues.) My right arm was pretty sore starting about mid-afternoon, so sore it hurt to move it. I took tylenol at bedtime and my arm felt better in the morning but I started feeling really achey and tired.  I ended up sleeping for another 2 hours, from 11am to 1pm. My body was really sore...shoulders, my right armpit, hips, lower back, knees, thighs. More so than normal. Lasted the full day after the shot. Felt much better on the 3rd day (April 11, 2021)
Pt was sitting in our waiting area for the 15 minutes time after receiving the vaccine.  Looked over to check on him and heard a noise and it looked like he had a small seizure.  He came to within 1 minute.  Called 911. Pt wanted to lie down on the floor. Allowed him to. Kept talking to him. He was pale in color and then vomited.  EMTs transported him to the hospital for evaluation.
Admitted 8/20 for GI bleed, dizziness and fatigue.  Resulted positive for COVID on 8/21.  Patient still hospitalized.
Nothing noticed right away. Hard muscle knot upper left arm, lasted weeks, maybe more. Distinct worsening of L hand dyskinesia. New symptom (worst) Parkinson-like tremor of L hand, not improving. Weakness and tremor noticed within a couple weeks (?) of shot, continues now three months later.
1410: Pt received vaccine felt faint immediately. Walked over to the 30 minute observation area and decided to lay down because symptoms weren't improving and loss of consciousness.  Denies nausea and vomiting, SOB and pain.   MedHx: Graves Disease Meds: Synthroid, Aggestin, Allergy Medications Allergies: Tapezole, Augmentin 1415: VS: 130/80; HR 82, Oxsat98% on RA RR 16, lying down 1430: VS: b/p 118/80, HR 84, O2Sat 96% on RA, 16-RR-Sitting 1440: VS: 108/64-B/p, HR 84, O2Sat 96% on RA, 16-RR 1445:  pt denies any further dizziness or clamminess, states she feels great. 1446: Discharged-patient ambulating well without issue. Verbalized understanding of what signs and symptoms to look our for and when to go to the ER.
Right shoulder and right side of the face experiencing numbness; This is a spontaneous report from a contactable consumer or other non hcp via a Pfizer-sponsored program COVAX US Support. A male patient of an unspecified age received first dose of BNT162B2 (BNT162B2, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Deltoid Right on 21Mar2021 as SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in Mar2021, the patient experienced the right shoulder and right side of the face experiencing numbness. The outcome of the event was unknown.  No follow-up attempts are Possible; information about lot/batch number cannot be obtained.
Case PHEH2012US016150, is an initial spontaneous report received from a health care professional (pharmacy student) on 13 Aug 2012. This report refers to an 18-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: A11052), intramuscularly on 13 Aug 2012. The patient received only the men A lyophilized component (powder) of MENVEO reconstituted with sterile water. The patient did not receive the men C, Y, W-135 liquid conjugate (solvent). No adverse event was reported.
PATIENT IS COMPLAINING HE STILL FEELS LIKE A PULLED MUSCLE OR TENDONITIS 105 DAYS LATER.
Vaccine given after physical. Pt fainted, vasovagal, hit head on carpeted cement floor. Loss of consciousness 1 min, had tonic posturing of right hand only some shaking.
Severe pain from from shoulder to hand. Lasted 3 weeks. Large swollen (hard) cervical lymph nodes. After 2 weeks the lymph nodes reduced in size, but still swollen after 4 weeks.  Peripheral neuropathy (burning sensation in palms and feet). Started about a week after vaccination. Hasn?t subsided 4 weeks after vaccination.
dizzy; feels very sick; tired; chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), ILLNESS (feels very sick), FATIGUE (tired), CHILLS (chills) and NAUSEA (nausea) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cholangitis (immunocompromised because of cholangitis).    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced DIZZINESS (dizzy), ILLNESS (feels very sick), FATIGUE (tired), CHILLS (chills) and NAUSEA (nausea). At the time of the report, DIZZINESS (dizzy), ILLNESS (feels very sick), FATIGUE (tired), CHILLS (chills) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-060561, MOD-2021-060561 (Patient Link).
my left nostril began to stream a fine line of blood.; Later thatevening, I experienced all of the listedside effects listen on your website,with the addition to a swollen tongueon the left side.; Immediately after the injection (left arm), I had swollen Lymph nodes from under arm/ breast up entire side.; I felt pressure on the top of my head on the same side.; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0162) via an unspecified route of administration in the left arm on 02May2021 at 09:30 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included Raynaud's and Vascular injury nos (recovered vascular incident). The patient was allergic to medications, food, or other products but unspecified. Concomitant medication was not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0150) via an unspecified route of administration in the left arm on 11Apr2021 at 09:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021 at 11:00 the patient experienced immediately after the injection (left arm) swollen lymph nodes from under arm/ breast up entire side. She felt pressure on the top of her head on the same side. An hour and half after the injection, the swelling was more noticeable and her left nostril began to stream a fine line of blood. The nose bleed lasted about 10 minutes. The patient generally does not get nose bleeds. Later that evening, she experienced all of the listed side effects listen on Pfizer vaccine website, with the addition to a swollen tongue on the left side. By Tuesday, most symptoms had subsided. Her tongue was still slightly swollen (Thursday). She could not find any information regarding this on Pfizer vaccine website. The patient had asked about the above events if they were normal. She was nervous about receiving additional boosters in the future without clarity to the nose bleed and tongue reactions. The patient had requested to bed contacted. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the adverse events. The clinical outcome of the events swollen lymph nodes, head pressure were recovered on 04May2021. The clinical outcome of the event nose bleed was recovered 02May2021 at 12:40.  The clinical outcome of the event swollen tongue was not recovered at the time of this report.    No follow-up attempts are needed. No further information is expected
Sweating; Nausea; This spontaneous case was reported by a health care professional and describes the occurrence of HYPERHIDROSIS (Sweating) and NAUSEA (Nausea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced HYPERHIDROSIS (Sweating) and NAUSEA (Nausea). At the time of the report, HYPERHIDROSIS (Sweating) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   11 hours after receiving the vaccine, patient woke up with sweating and nausea. The reporter stated that 3 bath towel was drenched with sweat.  Concomitant medications were not reported.  No treatment details were provided    Reporter did not allow further contact
Pt vaccinated with DTP developed unconsolable crying from 6:30PM until 5:00AM.
Headache, shivering, sweating, fatigue, soreness at injection site, nausea
This spontaneous report as received from a nurse refers to an adult patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 18-JAN-2018, the patient was vaccinated with improperly stored dose of RECOMBIVAX HB one time dose (lot # M001579, Expiry date: M001579) intramuscular for prophylaxis, which experienced a temperature excursion. It was unknown if there were previous temperature excursions. It was unknown if data logger was involved. There was no product quality complaint reported. As of 20-JAN-2018, the patient did not report an adverse reaction.
A report has been received from a Pharmacist concerning a Child, subject of unknown gender, who had been receiving Nasal FLUMIST. FLUMIST started on an unknown date. It was reported that Pharmacist's colleague accidentally administered both doses into a single nostril in 4 children approximately 2 weeks ago. The outcome of the event of accidentally administered both doses into a single nostril in 4 children is unknown. The report was considered to be non-serious.
This spontaneous report was received from a nurse referring to a currently 21 year old patient of unknown gender. The patient's medical history, drug reactions/allergies and concomitant medications were not provided. On unknown dates (reported as "7-10 years ago"), the patient was vaccinated with the first and the second dose of GARDASIL for prophylaxis at unspecified age (route of administration, lot# and expiration dates were unknown). The nurse stated that it was unknown what interval was between first dose and second dose of GARDASIL. No adverse effects were reported.
Pt states she experienced nerve pain radiating up her left side from where the shot was given. Experienced chills and fever the night of. Woke up the next morning and symptoms had resolved.
Throbbing pain started in left arm started six days after injection. Lasted for several hours. Started again the next day but closer to injection site.